B of A Securities Downgrades HOOKIPA Pharma to Underperform, Lowers Price Target to $0.5
B of A Securities analyst Alec Stranahan downgrades HOOKIPA Pharma (NASDAQ:HOOK) from Buy to Underperform and lowers the price target from $6 to $0.5.
Cheesecake Factory Analyst Downgrades Stock As 2023 Expectations Are Difficult To Hurdle
Wedbush analyst Nick Setyan has downgraded the rating of The Cheesecake Factory Incorporated (NASDAQ:CAKE) shares from Outperform to Neutral and lowered the…
DoorDash’s Slowing Orders & UBER Competition Trigger Downgrade By This Analyst
RBC Capital analyst Brad Erickson downgraded DoorDash Inc (NYSE:DASH) from Outperform to Sector Perform rating and lowered the price target from $70…
Canaccord Genuity Downgrades Canadian Imperial Bank to Hold, Lowers Price Target to C$66.5
Canaccord Genuity analyst Meny Grauman downgrades Canadian Imperial Bank (TSX:CM) from Buy to Hold and lowers the price target from C$75 to C$66.5.
BMO Capital Downgrades Pebblebrook Hotel to Market Perform, Lowers Price Target to $18
BMO Capital analyst Ari Klein downgrades Pebblebrook Hotel (NYSE:PEB) from Outperform to Market Perform and lowers the price target from $20 to $18.
Barclays Downgrades Black Knight to Equal-Weight, Announces $65 Price Target
Barclays analyst Manav Patnaik downgrades Black Knight (NYSE:BKI) from Overweight to Equal-Weight and announces $65 price target.
Barclays Downgrades Blackstone to Equal-Weight, Lowers Price Target to $90
Barclays analyst Benjamin Budish downgrades Blackstone (NYSE:BX) from Overweight to Equal-Weight and lowers the price target from $98 to $90.
Morgan Stanley Downgrades AvalonBay Communities to Equal-Weight, Lowers Price Target to $187
Morgan Stanley analyst Adam Kramer downgrades AvalonBay Communities (NYSE:AVB) from Overweight to Equal-Weight and lowers the price target from $225 to $187.
Oppenheimer Downgrades AppHarvest to Perform
Oppenheimer analyst Kristen Owen downgrades AppHarvest (NASDAQ:APPH) from Outperform to Perform.
Baird Downgrades Asana to Neutral, Lowers Price Target to $15
Baird analyst Rob Oliver downgrades Asana (NYSE:ASAN) from Outperform to Neutral and lowers the price target from $32 to $15.